These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7639214)

  • 21. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
    Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
    Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
    Chen TS; Tsay SH; Chang FY; Lee SD
    Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
    Sung JJ; Leung VK; Chung SC; Ling TK; Suen R; Cheng AF; Li AK
    Am J Gastroenterol; 1995 Sep; 90(9):1424-7. PubMed ID: 7661162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients.
    Rune SJ
    Scand J Gastroenterol Suppl; 1994; 205():45-7. PubMed ID: 7863241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
    Sobhani I; Flourié B; Lavergne A; Colimon R; Mignon M; Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1991; 15(5):412-20. PubMed ID: 2070962
    [No Abstract]   [Full Text] [Related]  

  • 32. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
    Gisbert JP; Boixeda D; de Rafael L; Redondo C; Martín de Argila C; Bermejo F
    Rev Esp Enferm Dig; 1996 May; 88(5):317-22. PubMed ID: 8764537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Helicobacter pylori: from harmless commensal to clinically significant disease factor].
    Labenz J; Börsch G
    Dtsch Med Wochenschr; 1992 Jun; 117(25):997-9. PubMed ID: 1611970
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eczema responsive to treatment for Helicobacter pylori.
    Wilson WH
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934
    [No Abstract]   [Full Text] [Related]  

  • 37. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
    Massarrat S; Ihm P; Koch HK
    Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.